Capvizr
THE DEAL, AT A GLANCE

Signet Therapeutics

From the announcement
01Who is involvedBacked by China Life Equity Investment, China Life for Series A extensionFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
02What happenedSignet Therapeutics raised Series A, announced 2026-11-04From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
03Why it mattersSignet Therapeutics' Series A extension has lead backing from China Life, placing the deal within a broad flow of Unclassified funding activity.From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Signet Therapeutics · Financing Record

Explore source-linked visual explanations for Signet Therapeutics. Unsupported claims are withheld while source review continues.

Record 15327 · Recorded date: 2026-11-04

What it does

Signet Therapeutics: illustrative category image
Illustrative image (biotech lab), not Signet Therapeutics's product · MatasNavickas / CC BY-SA 4.0

Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.

Open record 15327 →

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime